Clinical Trial Update: Zalutumumab in Head and Neck Cancer [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for zalutumumab in head and neck cancer across Phase 1 and Phase 2, with completed status and results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer
• Head and Neck Neoplasms

Drugs mentioned

• Zalutumumab (zalutumumab)

Snippet

Sponsor: Genmab | Conditions: Head and Neck Neoplasms | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2011-12-22